THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
1 hedge funds and large institutions have $0 invested in Theseus Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-69
Holders Change %
-98.57%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
69
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$71.7M |
| 2 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
-$16.6M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$13.2M |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$8.58M |
| 5 |
BlackRock
New York
|
-$5.77M |
